Literature DB >> 26698637

Pleuropulmonary Blastoma: Evolution of an Entity as an Entry into a Familial Tumor Predisposition Syndrome.

Louis P Dehner1,2, Yoav H Messinger1, Kris Ann P Schultz1, Gretchen M Williams1, Kathryn Wikenheiser-Brokamp1,3, D Ashley Hill1,4.   

Abstract

Pleuropulmonary blastoma (PPB) is the most common primary malignant neoplasm of the lung in children. Like other solid dysontogenic neoplasms, this tumor typically presents before 7 years of age. The earliest manifestation is the presence of a lung cyst(s), which is usually recognized in the first year of life and is difficult to differentiate on the basis of imaging studies from non-neoplastic cysts of early childhood. From a multilocular cyst, PPB has the potential to progress to a high-grade multipatterned primitive sarcoma. More than 65% of all affected children have a heterozygous germline mutation in DICER1. The DICER1 PPB familial tumor predisposition syndrome is initially recognized in most cases on the basis of PPB alone but also by several other unique and characteristic extrapulmonary tumors, including pediatric cystic nephroma, nasal chondromesenchymal hamartoma, nodular lesions of the thyroid, embryonal rhabdomyosarcoma of the cervix, and ciliary body medulloepithelioma.

Entities:  

Keywords:  DICER1; cystic nephroma; lung; pleuropulmonary blastoma; rhabdomyosarcoma

Mesh:

Substances:

Year:  2015        PMID: 26698637     DOI: 10.2350/15-10-1732-OA.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  14 in total

Review 1.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

Review 2.  Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Authors:  Sarah G Mitchell; Bojana Pencheva; Christopher C Porter
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

3.  DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations.

Authors:  Eduardo J Bardón-Cancho; Ana Haro-Díaz; Francisco J Alonso-García-de la Rosa; Jorge Huerta-Aragonés; Marina García-Morín; Felipe González-Martínez; Carmen Garrido-Colino
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

Review 4.  Fetal imaging of congenital lung lesions with postnatal correlation.

Authors:  Akosua Sintim-Damoa; Harris L Cohen
Journal:  Pediatr Radiol       Date:  2022-08-25

5.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

6.  DICER1 Syndrome: Characterization of the Ocular Phenotype in a Family-Based Cohort Study.

Authors:  Laryssa A Huryn; Amy Turriff; Laura A Harney; Ann Garrity Carr; Patricia Chevez-Barrios; Dan S Gombos; Radha Ram; Robert B Hufnagel; D Ashley Hill; Wadih M Zein; Kris Ann P Schultz; Rachel Bishop; Douglas R Stewart
Journal:  Ophthalmology       Date:  2018-10-17       Impact factor: 12.079

7.  Novel intronic DICER1 variation associated with pleuropulmonary blastoma in two siblings.

Authors:  Bruce D Leckey; John M Carney; Jessica M Sun; Elizabeth N Pavlisko
Journal:  BMJ Case Rep       Date:  2019-01-20

8.  Pleuropulmonary Blastoma: More Than a Lung Neoplasm of Childhood.

Authors:  Louis P Dehner; Kris Ann Schultz; D Ashley Hill
Journal:  Mo Med       Date:  2019 May-Jun

Review 9.  Imaging of DICER1 syndrome.

Authors:  R Paul Guillerman; William D Foulkes; John R Priest
Journal:  Pediatr Radiol       Date:  2019-10-16

10.  MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target.

Authors:  Federica Petrillo; Anna Iervolino; Miriam Zacchia; Adelina Simeoni; Cristina Masella; Giovanna Capolongo; Alessandra Perna; Giovambattista Capasso; Francesco Trepiccione
Journal:  Kidney Dis (Basel)       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.